Methods and compositions comprising FATP5 for use in the diagnosis and treatment of metabolic disorders
    2.
    发明申请
    Methods and compositions comprising FATP5 for use in the diagnosis and treatment of metabolic disorders 审中-公开
    包含用于诊断和治疗代谢紊乱的FATP5的方法和组合物

    公开(公告)号:US20050054022A1

    公开(公告)日:2005-03-10

    申请号:US10919608

    申请日:2004-08-17

    摘要: The present invention provides methods for the identification of agents, e.g., therapeutic agents, that inhibit Fatty Acid Transport 5 (FATP5) activity, and methods of treating diseases or conditions associated with FATP5 function, e.g., obesity, insulin resistance, type 2 diabetes, dyslipidemia, fatty liver disease, and cardiovascular disease. Further aspects of the invention provide a transgenic FATP5 non-human knockout mammal, e.g., mouse, useful for elucidating the function of FATP5 in intact animals whose genomes comprise a wild-type FATP5 gene.

    摘要翻译: 本发明提供了用于鉴定抑制脂肪酸转运5(FATP5)活性的药剂,例如治疗剂的方法,以及治疗与FATP5功能相关的疾病或病症的方法,例如肥胖,胰岛素抵抗,2型糖尿病, 血脂异常,脂肪肝疾病和心血管疾病。 本发明的其它方面提供了转基因FATP5非人敲除哺乳动物(例如小鼠),其用于阐明在其基因组包含野生型FATP5基因的完整动物中FATP5的功能。

    HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR
    4.
    发明申请
    HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR 审中-公开
    人类胆固醇ACYLTRANSFERASE 2(DGAT2)家族成员及其用途

    公开(公告)号:US20070166748A1

    公开(公告)日:2007-07-19

    申请号:US11684365

    申请日:2007-03-09

    摘要: The present invention relates to compositions and methods for the diagnosis and treatment of obesity and related metabolic disorders. The invention provides isolated nucleic acids molecules, designated DGAT2 family member nucleic acid molecules, which encode diacylglycerol acyltransferase family members. The invention also provides recombinant expression vectors containing DGAT2 family member nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DGAT2 family member gene has been introduced or disrupted. The invention still further provides isolated DGAT2 family member proteins, fusion proteins, antigenic peptides and anti-DGAT2 family member antibodies. Methods of use of the provided DGAT2 family member compositions for screening, diagnostic and therapeutic methods in connection, with obesity disorders are also disclosed.

    摘要翻译: 本发明涉及用于诊断和治疗肥胖症及相关代谢紊乱的组合物和方法。 本发明提供编码二酰基甘油酰基转移酶家族成员的分离的核酸分子,称为DGAT2家族成员核酸分子。 本发明还提供了含有DGAT2家族成员核酸分子的重组表达载体,已引入表达载体的宿主细胞,以及导入或破坏了DGAT2家族成员基因的非人类转基因动物。 本发明还进一步提供分离的DGAT2家族成员蛋白,融合蛋白,抗原肽和抗DGAT2家族成员抗体。 还公开了所提供的DGAT2家族成员组合物用于与肥胖症有关的筛选,诊断和治疗方法的方法。